hct116 cell line (ATCC)
Structured Review

Hct116 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 80 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hct116 cell line/product/ATCC
Average 96 stars, based on 80 article reviews
Images
1) Product Images from "FAM65A, as a potential predictor of prognosis, promotes colorectal cancer progression via activating Ras/ERK/RSK signaling"
Article Title: FAM65A, as a potential predictor of prognosis, promotes colorectal cancer progression via activating Ras/ERK/RSK signaling
Journal: iScience
doi: 10.1016/j.isci.2026.114662
Figure Legend Snippet: Ectopic expression of FAM65A promotes CRC cell proliferation, migration, and inhibits cell apoptosis in vitro (A) Western blot analysis the efficiency of FAM65A overexpression, accompanied by a quantitative assessment, n = 3, ∗∗ p < 0.01. (B) The findings from the CCK8 assay conducted on HCT116-MCS and HCT116-FAM65A cells are presented, n = 3, ∗∗∗ p < 0.001. (C) The outcomes of the colony formation assay for HCT116-MCS and HCT116-FAM65A cells are reported. (D) A quantitative analysis of the colony formation assay results is provided, n = 3, ∗∗∗ p < 0.001. (E) The results of the EdU assay in HCT116-MCS and HCT116-FAM65A cells are shown. Scale bars, 100 μm. (F) A quantitative analysis of the EdU assay results is included, n = 3, ∗∗∗ p < 0.001. (G) The findings from the apoptosis assay in HCT116-MCS and HCT116-FAM65A cells are presented. (H) A quantitative analysis of the apoptosis assay results is provided, n = 3, ∗∗∗ p < 0.001. (I) The results of the transwell migration assay for HCT116-MCS and HCT116-FAM65A cells are reported. Scale bars, 50 μm. (J) A quantitative analysis of the transwell migration assay results is included, n = 3, ∗∗∗ p < 0.001. (K) The outcomes of the wound healing assay in HCT116-MCS and HCT116-FAM65A cells are presented. Scale bars, 50 μm. (L) A quantitative analysis of the wound healing assay results is provided, n = 3, ∗∗ p < 0.01. (M) The western blot analysis illustrates the expression levels of Ki-67, cleaved caspase 3, Bcl-2, Bax, E-cadherin, N-cadherin, β-catenin, and vimentin in HCT116-MCS and HCT116-FAM65A cells. Data are presented as mean ± SEM of biologically independent experiments.
Techniques Used: Expressing, Migration, In Vitro, Western Blot, Over Expression, CCK-8 Assay, Colony Assay, EdU Assay, Apoptosis Assay, Transwell Migration Assay, Wound Healing Assay
Figure Legend Snippet: FAM65A promotes CRC tumor progression is dependent on RSK phosphorylation (A) Results from protein kinase microarray analysis of HCT116-MCS and HCT116-FAM65A cells. (B) Quantitative assessment of the protein kinase microarray data, n = 2. (C) Western blot analysis demonstrating the expression levels of p -RSK and total RSK in HCT116-MCS and HCT116-FAM65A cells. (D) Western blot analysis of p -RSK and RSK expression in HCT116-FAM65A cells treated with 4 and 8 μM BRD7389 or without treatment. (E) Results from the CCK8 cell proliferation assay conducted on HCT116-FAM65A cells with and without the application of BRD7389, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (F) Outcomes of the colony formation assay performed on HCT116-FAM65A cells treated with BRD7389 or without treatment. (G) Quantitative analysis of the colony formation assay results, n = 3, ∗∗∗ p < 0.001. (H) Results from the EdU assay conducted on HCT116-FAM65A cells with and without the application of BRD7389. Scale bars, 100 μm. (I) Quantitative analysis of the EdU assay results, n = 3, ∗∗∗ p < 0.001. (J) Western blot analysis of Ki-67 expression in HCT116-FAM65A cells treated with BRD7389 or not. (K) Results from the apoptosis assay conducted on HCT116-FAM65A cells treated with BRD7389 or not. Scale bars, 50 μm. (L) Quantitative analysis of the apoptosis experiments, n = 3, ∗∗∗ p < 0.001. (M) Western blot analysis of the expression levels of cleaved Caspase 3, Bcl-2, and Bax in HCT116-FAM65A cells treated with BRD7389 or not. (N) Results from the Transwell migration assay conducted on HCT116-FAM65A cells with and without the application of BRD7389. Scale bars, 50 μm. (O) Quantitative analysis of the Transwell migration assay results, n = 3, ∗∗∗ p < 0.001. (P) Results from the wound healing assay performed on HCT116-FAM65A cells treated with BRD7389 or not. Scale bars, 50 μm. (Q) Quantitative analysis of the wound healing assay results, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (R) Western blot analysis the expression of EMT markers in HCT116-FAM65A cells treated with BRD7389 or not. Data are presented as mean ± SEM of biologically independent experiments.
Techniques Used: Phospho-proteomics, Microarray, Western Blot, Expressing, Proliferation Assay, Colony Assay, EdU Assay, Apoptosis Assay, Transwell Migration Assay, Wound Healing Assay
Figure Legend Snippet: Ras/ERK signaling activation was indispensable for FAM65A-mediated RSK activation and CRC progression (A) Western blot analysis of Ras and p -ERK expression in HCT116-FAM65A cells treated with 10 μM Abd-7, or without treatment. (B) Results from the CCK8 cell proliferation assay conducted on HCT116-FAM65A cells with and without the application of Abd-7, n = 3, ∗∗∗ p < 0.001. (C) Colony formation assay performed on HCT116-FAM65A cells treated with Abd-7 or not. (D) Quantitative analysis of the colony formation assay results, n = 3, ∗∗∗ p < 0.001. (E) Results from the EdU assay conducted on HCT116-FAM65A cells with and without the application of Abd-7. Scale bars, 100 μm. (F) Quantitative analysis of the EdU assay results, n = 3, ∗∗∗ p < 0.001. (G) Western blot analysis of Ki-67, cleaved Caspase 3, Bcl-2, and Bax expression in HCT116-FAM65A cells treated with Abd-7 or not. (H) Results from the apoptosis assay conducted on HCT116-FAM65A cells treated with Abd-7 or not. Scale bars, 50 μm. (I) Quantitative analysis of the apoptosis experiments, n = 3, ∗∗∗ p < 0.001. (J) Results from the Transwell migration assay conducted on HCT116-FAM65A cells with and without the application of Abd-7. Scale bars, 50 μm. (K) Quantitative analysis of the Transwell migration assay results, n = 3, ∗∗∗ p < 0.001. (L) Results from the wound healing assay performed on HCT116-FAM65A cells treated with Abd-7 or not. Scale bars, 50 μm. (M) Quantitative analysis of the wound healing assay results, n = 3, ∗∗∗ p < 0.001. (N) Western blot analysis the expression of EMT markers in HCT116-FAM65A cells treated with Abd-7 or not. (O) Proposed model of FAM65A in CRC progression. Data are presented as mean ± SEM of biologically independent experiments.
Techniques Used: Activation Assay, Western Blot, Expressing, Proliferation Assay, Colony Assay, EdU Assay, Apoptosis Assay, Transwell Migration Assay, Wound Healing Assay



